Candela GentleMAX

Details Combining the capabilities of two Best-in-Class lasers GentleLASE and GentleYAG Candela announces GentleMAX the first multiple wavelength workstation uniquely configured to address aesthetic medicines most commonly requested procedures, including permanent hair reduction, leg and facial vein removal, vascular and pigmented lesion removal and skin tightening. The GentleMAX offers practitioners the same unsurpassed speed, efficacy […]

Non-Melanoma Skin Cancer Outcomes

Dr. William Roth presents three cases of non-melanoma skin cancer being treated by Superficial Radiation Therapy (SRT). Look at these amazing results!

Skin Cancer and SRT – Jeff Goldstein Interview

All transplant patients have a greater chance of developing skin cancer compared to the general population. In fact, research shows that transplant recipients have up to a 100 times higher risk for developing skin cancer compared to the general population. Transplant patients tend to develop a skin cancer called squamous cell carcinoma (SCC) although many patients will […]

The Dermatology Digest – Superficial Radiation Therapy Clinical Benefits and Studies

Not all treatment modalities for non-melanoma skin cancer are the same. In Part 2 of this video series, Dr. Mark Nestor discusses studies that demonstrate the clinical benefits of SRT, including cure rate, cosmesis, and consensus guidelines. About This Series In this 3-part educational series, Dr. Mark Nestor reviews the core concepts and treatment modalities […]

Sensus Healthcare Announces New $3 Million Share Repurchase Program

BOCA RATON, Fla., Aug. 08, 2023 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that its Board of Directors has authorized a new share repurchase program under which the Company may repurchase up to $3.0 million of its […]

Sensus Healthcare Announces New $3 Million Share Repurchase Program

BOCA RATON, Fla., Aug. 08, 2023 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that its Board of Directors has authorized a new share repurchase program under which the Company may repurchase up to $3.0 million of its […]

Sensus Healthcare Reports Second Quarter 2023 Financial Results

Revenues increased 33% and system shipments increased 30%, both compared with the first quarter of 2023 Achieved a milestone with the installation of 700 systems for a total of 708 Expects to ship at least 60 SRT units during 2023 and to return to profitability in the second half of the year Conference call begins […]